Group One Trading
ENVB icon

Group One Trading’s Enveric Biosciences ENVB Stock Holding History

Group One Trading’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed -$4K – 7689
2022
Q2 		$4K Hold
2
– – ﹤0.01% 7187
2022
Q1 		$7K Hold
2
– – ﹤0.01% 7288
2021
Q4 		$17K Buy
+2
New +$28.1K ﹤0.01% 7055

Other funds holding ENVB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's ENVB Position: Q1 2026 in Review

Group One Trading held its Enveric Biosciences (ENVB) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7484.

Group One Trading first reported a position in ENVB in Q4 2021 and has held it in 16 quarters since. The position peaked at $49K in Q4 2021. 11 funds tracked by Wall St. Rank hold ENVB as of Q1 2026.

  • Group One Trading held 1 share of Enveric Biosciences worth $2 as of Q1 2026.
  • Group One Trading left its Enveric Biosciences share count unchanged in Q1 2026.
  • Enveric Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7484 holding.
  • Group One Trading first reported a position in Enveric Biosciences in Q4 2021 and has held it in 16 quarters since.
  • Group One Trading's Enveric Biosciences position peaked at $49K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.